|
🐜
|
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study
24 auth.
J. Haschka,
M. Englbrecht,
A. Hueber,
B. Manger,
A. Kleyer,
M. Reiser,
S. Finzel,
H. Tony,
S. Kleinert,
M. Feuchtenberger,
...
M. Fleck,
K. Manger,
W. Ochs,
M. Schmitt-Haendle,
J. Wendler,
F. Schuch,
M. Ronneberger,
H. Lorenz,
H. Nuesslein,
R. Alten,
W. Demary,
J. Henes,
G. Schett,
J. Rech
|
7 |
2015 |
7
🐜
|
|
🐜
|
Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.
9 auth.
C. Antoni,
C. Dechant,
P. D. Hanns-Martin Lorenz,
J. Wendler,
A. Ogilvie,
Mathias Lueftl,
...
D. Kalden-Nemeth,
J. Kalden,
B. Manger
|
7 |
2002 |
7
🐜
|
|
🐜
|
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
26 auth.
J. Rech,
A. Hueber,
S. Finzel,
M. Englbrecht,
J. Haschka,
B. Manger,
A. Kleyer,
M. Reiser,
J. Cobra,
C. Figueiredo,
H. Tony,
S. Kleinert,
J. Wendler,
F. Schuch,
M. Ronneberger,
...
M. Feuchtenberger,
M. Fleck,
K. Manger,
W. Ochs,
M. Schmitt-Haendle,
H. Lorenz,
H. Nuesslein,
R. Alten,
J. Henes,
K. Krueger,
G. Schett
|
6 |
2015 |
6
🐜
|
|
🦁
|
Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients
11 auth.
J. Wendler,
G. Burmester,
H. Sörensen,
A. Krause,
C. Richter,
H. Tony,
...
A. Rubbert-Roth,
P. Bartz-Bazzanella,
S. Wassenberg,
I. Haug-Rost,
T. Dörner
|
5 |
2014 |
5
🦁
|
|
🐜
|
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs
27 auth.
C. Figueiredo,
H. Bang,
J. Cobra,
M. Englbrecht,
A. Hueber,
J. Haschka,
B. Manger,
A. Kleyer,
M. Reiser,
S. Finzel,
H. Tony,
S. Kleinert,
J. Wendler,
F. Schuch,
M. Ronneberger,
...
M. Feuchtenberger,
M. Fleck,
K. Manger,
W. Ochs,
M. Schmitt-Haendle,
H. Lorenz,
H. Nuesslein,
R. Alten,
J. Henes,
K. Krueger,
J. Rech,
G. Schett
|
5 |
2016 |
5
🐜
|
|
🐢
|
Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge
20 auth.
M. Englbrecht,
R. Alten,
M. Aringer,
Christoph Baerwald,
H. Burkhardt,
N. Eby,
G. Fliedner,
B. Gauger,
U. Henkemeier,
Michael W. Hofmann,
...
S. Kleinert,
C. Kneitz,
K. Krueger,
C. Pohl,
A. Roske,
G. Schett,
M. Schmalzing,
A. Tausche,
Hans Peter Tony,
J. Wendler
|
5 |
2017 |
5
🐢
|
|
🐜
|
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial.
28 auth.
K. Tascilar,
M. Hagen,
A. Kleyer,
D. Simon,
M. Reiser,
A. Hueber,
B. Manger,
M. Englbrecht,
S. Finzel,
H. Tony,
F. Schuch,
S. Kleinert,
J. Wendler,
M. Ronneberger,
C. Figueiredo,
...
J. Cobra,
M. Feuchtenberger,
M. Fleck,
K. Manger,
W. Ochs,
M. Schmitt-Haendle,
Hanns-Martin Lorenz,
H. Nuesslein,
R. Alten,
K. Kruger,
J. Henes,
G. Schett,
J. Rech
|
3 |
2021 |
3
🐜
|
|
🐜
|
Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.
16 auth.
Stefan Kleinert,
Florian Schuch,
Praxedis Rapp,
M. Ronneberger,
J. Wendler,
P. Sternad,
F. Popp,
P. Bartz-Bazzanella,
C. von der Decken,
Kirsten Karberg,
...
G. Gauler,
Patrick Wurth,
Susanna Späthling-Mestekemper,
Christoph Kuhn,
W. Vorbrüggen,
M. Welcker
|
2 |
2023 |
2
🐜
|
|
🐜
|
Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis
18 auth.
S. Kleinert,
F. Schuch,
Praxedis Rapp,
M. Ronneberger,
J. Wendler,
P. Sternad,
F. Popp,
P. Bartz-Bazzanella,
C. von der Decken,
K. Karberg,
...
G. Gauler,
Patrick Wurth,
Susanna Späthling-Mestekemper,
C. Kuhn,
M. Englbrecht,
W. Vorbrüggen,
G. Adler,
M. Welcker
|
2 |
2022 |
2
🐜
|
